NSEGeneral Updates29 Jul 2026 · 29 Jul 2026, 04:53 pm

General Updates

Aurobindo Pharma Limited · AUROPHARMA

✦ AI SummaryResults

Aurobindo Pharma Limited has announced the date of its 39th Annual General Meeting, scheduled to be held on August 27, 2026, through video conferencing. The notice and integrated annual report for the financial year 2025-26 will be sent to registered shareholders and made available on the company's website.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Aurobindo Pharma Limited has iIntimated the date of 39th Annual General Meeting of Aurobindo Pharma Limited.

Attachments (1)

📄

AUROPHARMA_29072026165321_LtrToSEsIntimationofDate39thAGM29072026.pdf

pdf

Download →
View document text
July 29, 2026 To To Listing Department, The Corporate Relations Department NATIONAL STOCK EXCHANGE OF INDIA LIMITED BSE LIMITED Exchange Plaza, Phiroz Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (E), 25th floor, Dalal Street, MUMBAI -400 051 MUMBAI -400 001 Company Code No. AUROPHARMA Company Code No. 524804 Dear Sir/Madam, Sub: Intimation of 39th Annual General Meeting of Aurobindo Pharma Limited. This is to inform you that the 39th Annual General Meeting (“AGM”) of members of the Company is scheduled to be held on Thursday, August 27, 2026, at 3:30 p.m. IST through Video Conferencing ("VC") / Other Audio Visual Means ("OAVM"). The Notice of the 39th Annual General Meeting and Integrated Annual Report for the financial year 2025-26 will be sent to all shareholders whose email IDs are registered with the Company / Depositories and will also be made available on the Company's website at https://www.aurobindo.com/investors/disclosures-under- regulation-46/financial-information/annual-reports in due course. For those shareholders whose email IDs are not registered with the Company / Depositories, a letter containing the weblink and path will be sent to access the Notice of the 39th Annual General Meeting and Integrated Annual Report for the financial year 2025-26. Pursuant to Section 91 of the Companies Act, 2013 and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Register of Members and Share Transfer Books will remain closed from Wednesday, August 26, 2026 to Thursday, August 27, 2026 (both days inclusive) for the purpose of AGM. Please take the information on record. Thanking you, Yours faithfully, For AUROBINDO PHARMA LIMITED B. Adi Reddy Company Secretary Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India. Tel : +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044. Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038 , Telangana, India Tel: +91 40 2373 6370/ 2374 7340 Fax: +91 40 2374 1080 / 2374 6833 Email: info@aurobindo.com Website: www.aurobindo.com